Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
46,611,235
-
Share change
-
+1,886,841
-
Total reported value
-
$3,597,430,281
-
Put/Call ratio
-
173%
-
Price per share
-
$77.18
-
Number of holders
-
313
-
Value change
-
+$167,666,485
-
Number of buys
-
168
-
Number of sells
-
109
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2017
As of 30 Jun 2017 SPDR SERIES TRUST - S&P BIOTECH (XBI) had 313 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 46,611,235 shares of stock of the company.
Largest 10 holders included CITIGROUP INC, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, BNP PARIBAS ARBITRAGE, SA, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, UBS Group AG, Quantitative Investment Management, LLC, WELLS FARGO & COMPANY/MN, and ASSETMARK, INC.
This table shows 313 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.